Preclinical findings have shown matrix metalloproteinase 7 (MMP-7) inhibition confers antifibrotic effects and thus, is a promising therapeutic strategy to treat idiopathic pulmonary fibrosis (IPF).
Matrix metalloproteinases are a biologically plausible and promising biomarker for rapid disease progression in ADPKD and CKD in general. Matrix metalloproteinases may predict rapid disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback